FUSOMAB

USPTO USPTO 2007 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke FUSOMAB wurde als Wortmarke am 12.07.2007 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 07.08.2012 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 12. August 2019

Markenform Wortmarke
Aktenzeichen 77227864
Registernummer 4184636
Anmeldedatum 12. Juli 2007
Veröffentlichungsdatum 22. Mai 2012
Eintragungsdatum 07. August 2012

Markeninhaber

7895 TRANMERE DRIVE, SUITE 204
L5S 1V9 MISSISSAUGA, ONTARIO
CA

Markenvertreter

Waren und Dienstleistungen

1 Biotechnology preparations for commercial purposes, namely, for use in the manufacture of biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and/or medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
5 Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and/or benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use
42 Medical and scientific research and development services, namely, preparation and development of proteins and preparation and development services, namely, preparation and development of proteins and preparation and development of in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others; preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1377227864